At the time of writing, the study of the CD27-CD70 pathway in GVHD remains confined to murine and cellular models, with ongoing studies seeking to better understand the effect of CD27 agonism on donor hematopoietic cell differentiation, engraftment, and GVT effect. This evidence concerns the gene CD70 and graft versus host disease.